Tolterodine and cardiac failure Patient Reports February 11, 2012
Tolterodine Side Effects Report #4702213-8
Tolterodine side effect was reported by a Consumer or non-health professional from on Jan 27, 2005. Female patient, 76 years of age, weighting 135.0 lb, was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cardiac failure, constipation
, diarrhoea, sciatica
. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with METOPROLOL TARTRATE, SOTALOL, VALSARTAN, VITAMIN E, VITAMINS, FISH OIL. Patient recovered.Tolterodine Side Effects Report #5655974-8
Tolterodine side effect was reported by a Physician from JAPAN on Feb 26, 2008. Male patient, 70 years of age, was diagnosed with hypertonic bladder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cardiac failure. Tolterodine dosage: DAILY DOSE:4MG. During the same period patient was treated with OLMESARTAN MEDOXOMIL, AMLODIN, WARFARIN. Patient was hospitalized. Patient recovered.
Tolterodine Side Effects Report #5662308-1
Tolterodine side effect was reported by a Physician from JAPAN on Feb 29, 2008. Male patient was diagnosed with hypertonic bladder, hypertension and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cardiac failure. Tolterodine dosage: DAILY DOSE:2MG. During the same period patient was treated with OLMESARTAN MEDOXOMIL, AMLODIN, WARFARIN. Patient was hospitalized. Patient recovered.
Tolterodine Side Effects Report #5192200-0
Tolterodine side effect was reported by a Consumer or non-health professional from on Dec 08, 2006. Female patient was diagnosed with bladder disorder and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: anorexia, asthenia, cardiac failure, coma, loss of consciousness, pain in extremity, viral infection
, vomiting. Tolterodine dosage: 4 MG (4 MG, 1 IN 1 D), ORAL. During the same period patient was treated with ANTIINFLAMMATORY. Patient was hospitalized. Patient died on 12/02/2006.Tolterodine Side Effects Report #5705009-3
Tolterodine side effect was reported by a Physician from UNITED STATES on Apr 04, 2008. Male patient, 74 years of age, was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cardiac failure. Tolterodine dosage: unknown. During the same period patient was treated with OLMESARTAN MEDOXOMIL, WARFARIN, AMLODIPINE BESYLATE, JUVELA, NABOAL, MUCOSTA, LIPITOR, GLYCYRON. Patient was hospitalized. Patient recovered.
Tolterodine Side Effects Report #5733830-4
Tolterodine side effect was reported by a Physician from UNITED STATES on Apr 29, 2008. Male patient, 74 years of age, was diagnosed with essential hypertension and was treated with Tolterodine. After drug was administered, patient experienced the following side effects: cardiac failure. Tolterodine dosage: unknown. During the same period patient was treated with OLMETEC, WARFARIN, AMLODIPINE BESILATE, JUVELA, NABOAL, MUCOSTA, LIPITOR, GLYCYRON. Patient was hospitalized. Patient recovered.
Tolterodine and cardiac failure 